
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5011385
[patent_doc_number] => 20070281864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Methods of identifying insect-specific spider toxin mimics'
[patent_app_type] => utility
[patent_app_number] => 11/810681
[patent_app_country] => US
[patent_app_date] => 2007-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14711
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281864.pdf
[firstpage_image] =>[orig_patent_app_number] => 11810681
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/810681 | Methods of identifying insect-specific spider toxin mimics | Jun 5, 2007 | Abandoned |
Array
(
[id] => 5398267
[patent_doc_number] => 20090318330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'COMBINATION OF AMINO ACID SOLUTION AND A GELATIN DERIVATIVE FOR INHIBITING RENAL UP-TAKE'
[patent_app_type] => utility
[patent_app_number] => 12/303090
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1714
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12303090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/303090 | Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take | May 30, 2007 | Issued |
Array
(
[id] => 43287
[patent_doc_number] => 07776573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Crystal structure of CRIg and C3b:CRIg complex'
[patent_app_type] => utility
[patent_app_number] => 11/809353
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27087
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809353 | Crystal structure of CRIg and C3b:CRIg complex | May 29, 2007 | Issued |
Array
(
[id] => 6507866
[patent_doc_number] => 20100216239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'ISOLATED NATURE-IDENTICAL COLLAGEN'
[patent_app_type] => utility
[patent_app_number] => 12/302667
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6940
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216239.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302667 | Isolated nature-identical collagen | May 29, 2007 | Issued |
Array
(
[id] => 303459
[patent_doc_number] => 07534595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 11/807227
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 36580
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11807227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/807227 | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof | May 24, 2007 | Issued |
Array
(
[id] => 5331491
[patent_doc_number] => 20090111968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Self-assembled proteins and related methods and protein structures'
[patent_app_type] => utility
[patent_app_number] => 11/805188
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 17657
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111968.pdf
[firstpage_image] =>[orig_patent_app_number] => 11805188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/805188 | Self-assembled proteins and related methods and protein structures | May 21, 2007 | Issued |
Array
(
[id] => 5441975
[patent_doc_number] => 20090093614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'SELF-ASSEMBLED PROTEINS AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 11/751850
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3394
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11751850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/751850 | SELF-ASSEMBLED PROTEINS AND RELATED METHODS | May 21, 2007 | Abandoned |
Array
(
[id] => 4903993
[patent_doc_number] => 20080113406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'MODIFIED BACTERIOCINS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 11/748432
[patent_app_country] => US
[patent_app_date] => 2007-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23000
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11748432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/748432 | Modified bacteriocins and methods for their use | May 13, 2007 | Issued |
Array
(
[id] => 292488
[patent_doc_number] => 07544780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Prokaryotic collagen-like proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/800288
[patent_app_country] => US
[patent_app_date] => 2007-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 53
[patent_no_of_words] => 14519
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544780.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800288 | Prokaryotic collagen-like proteins and uses thereof | May 3, 2007 | Issued |
Array
(
[id] => 296180
[patent_doc_number] => 07541451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Fluorescent proteins from Fungia '
[patent_app_type] => utility
[patent_app_number] => 11/739133
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9655
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541451.pdf
[firstpage_image] =>[orig_patent_app_number] => 11739133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/739133 | Fluorescent proteins from Fungia | Apr 23, 2007 | Issued |
Array
(
[id] => 4561020
[patent_doc_number] => 07838629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography'
[patent_app_type] => utility
[patent_app_number] => 11/732632
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 22036
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838629.pdf
[firstpage_image] =>[orig_patent_app_number] => 11732632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/732632 | Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography | Apr 3, 2007 | Issued |
Array
(
[id] => 4909647
[patent_doc_number] => 20080020413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'CRYSTALLINE VISFATIN AND METHODS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 11/693536
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13983
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020413.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693536 | CRYSTALLINE VISFATIN AND METHODS THEREFOR | Mar 28, 2007 | Abandoned |
Array
(
[id] => 5177499
[patent_doc_number] => 20070178559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Platelet promoting protein and the usage thereof'
[patent_app_type] => utility
[patent_app_number] => 11/729727
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3469
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11729727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/729727 | Platelet promoting protein and the usage thereof | Mar 28, 2007 | Abandoned |
Array
(
[id] => 5564107
[patent_doc_number] => 20090136960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE IDENTIFICATION OF CANCER MARKERS'
[patent_app_type] => utility
[patent_app_number] => 12/294316
[patent_app_country] => US
[patent_app_date] => 2007-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17253
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294316
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294316 | METHODS AND COMPOSITIONS FOR THE IDENTIFICATION OF CANCER MARKERS | Mar 25, 2007 | Abandoned |
Array
(
[id] => 267040
[patent_doc_number] => 07566565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'PC5 as a factor IX propeptide processing enzyme'
[patent_app_type] => utility
[patent_app_number] => 11/728045
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27594
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728045
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728045 | PC5 as a factor IX propeptide processing enzyme | Mar 22, 2007 | Issued |
Array
(
[id] => 5453511
[patent_doc_number] => 20090069548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Immobilized Proteins and Methods and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/225359
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5269
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225359 | Immobilized proteins and methods and uses thereof | Mar 21, 2007 | Issued |
Array
(
[id] => 9233013
[patent_doc_number] => 08598317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4'
[patent_app_type] => utility
[patent_app_number] => 12/293715
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 18
[patent_no_of_words] => 21655
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12293715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293715 | Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4 | Mar 19, 2007 | Issued |
Array
(
[id] => 296179
[patent_doc_number] => 07541450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Ligand-dependent protein splicing'
[patent_app_type] => utility
[patent_app_number] => 11/688073
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 14652
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541450.pdf
[firstpage_image] =>[orig_patent_app_number] => 11688073
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/688073 | Ligand-dependent protein splicing | Mar 18, 2007 | Issued |
Array
(
[id] => 5196589
[patent_doc_number] => 20070295907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Method and apparatus for use of thermally switching proteins in sensing and detecting devices'
[patent_app_type] => utility
[patent_app_number] => 11/724178
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13514
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0295/20070295907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724178 | Method and apparatus for use of thermally switching proteins in sensing and detecting devices | Mar 14, 2007 | Abandoned |
Array
(
[id] => 326761
[patent_doc_number] => 07514532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor'
[patent_app_type] => utility
[patent_app_number] => 11/715600
[patent_app_country] => US
[patent_app_date] => 2007-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20188
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514532.pdf
[firstpage_image] =>[orig_patent_app_number] => 11715600
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/715600 | Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor | Mar 6, 2007 | Issued |